Specifically, patients treated with insulin monotherapy, but also in combination with statins, metformin or DPP-IV inhibitors, had an increased risk of diagnosis of pneumonia when compared to individuals without antidiabetic drug therapy. This evidence concerns the gene INS and susceptibility to pneumonia measurement.